Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 30 of 30 entries
View as:

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05629962 Org: User:
Start: 11/25/22 End: 05/30/24 Due: 05/30/25

Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT04019717 Org: User:
Start: 06/20/19 End: 03/23/20 Due: 03/23/21

Study of AT-527 in Subjects With Normal and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT05618314 Org: User:
Start: 10/17/22 End: 06/15/24 Due: 06/15/25

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT06911320 Org: User:
Start: 04/09/25 End: 08/31/25 Due: 08/31/26

Study of AT-527 in Healthy Subjects (R07496998)

Phase: N/A Priority: Normal
NCT ID: NCT04711187 Org: User:
Start: 11/02/20 End: 09/15/21 Due: 09/15/22